Rheumatoid arthritis and lymphoma: Incidence, pathogenesis, biology, and outcome
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rheumatoid arthritis and lymphoma: Incidence, pathogenesis, biology, and outcome
Authors
Keywords
-
Journal
HEMATOLOGICAL ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-06-04
DOI
10.1002/hon.2525
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TNF inhibitors in rheumatoid arthritis and spondyloarthritis: Are they the same?
- (2018) Andrea Rubbert-Roth et al. AUTOIMMUNITY REVIEWS
- Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
- (2016) Louise K Mercer et al. ANNALS OF THE RHEUMATIC DISEASES
- The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance
- (2016) E. Zucca et al. BLOOD
- Malignancy risk of anti-tumor necrosis factor alpha blockers: an overview of systematic reviews and meta-analyses
- (2015) Yuehong Chen et al. CLINICAL RHEUMATOLOGY
- The Comparative Safety of Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis: A Meta-analysis Update of 44 Trials
- (2014) Tzeyu L. Michaud et al. AMERICAN JOURNAL OF MEDICINE
- Hodgkin lymphoma after autoimmune diseases by age at diagnosis and histological subtype
- (2014) M. Fallah et al. ANNALS OF ONCOLOGY
- Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis
- (2014) Sofia Ramiro et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of Breast Cancer and Total Malignancies in Rheumatoid Arthritis Patients Undergoing TNF-α Antagonist Therapy: a Meta-analysis of Randomized Control Trials
- (2014) Yang Liu et al. Asian Pacific Journal of Cancer Prevention
- Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression
- (2013) Ayako Ichikawa et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Risk of Malignancies in Patients With Rheumatoid Arthritis Treated With Biologic Therapy
- (2012) Maria A. Lopez-Olivo et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Short-term Risk of Total Malignancy and Nonmelanoma Skin Cancers with Certolizumab and Golimumab in Patients with Rheumatoid Arthritis: Metaanalysis of Randomized Controlled Trials
- (2012) P. LE BLAY et al. JOURNAL OF RHEUMATOLOGY
- Cancer Risk of Anti-TNF-α at Recommended Doses in Adult Rheumatoid Arthritis: A Meta-Analysis with Intention to Treat and per Protocol Analyses
- (2012) Guillaume Moulis et al. PLoS One
- Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population
- (2012) L. K. Mercer et al. RHEUMATOLOGY
- Observational studies on the risk of cancer associated with tumor necrosis factor inhibitors in rheumatoid arthritis: A review of their methodologies and results
- (2011) D. H. Solomon et al. ARTHRITIS AND RHEUMATISM
- Tumor necrosis factor therapy and the risk of serious infection and malignancy in patients with early rheumatoid arthritis: A meta-analysis of randomized controlled trials
- (2011) Andrew E. Thompson et al. ARTHRITIS AND RHEUMATISM
- Risk of lymphoma in patients receiving antitumor necrosis factor therapy: a meta-analysis of published randomized controlled studies
- (2011) Anna K. Wong et al. CLINICAL RHEUMATOLOGY
- Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA
- (2010) J. L. Nam et al. ANNALS OF THE RHEUMATIC DISEASES
- Do rheumatoid arthritis and lymphoma share risk factors?: A comparison of lymphoma and cancer risks before and after diagnosis of rheumatoid arthritis
- (2010) Karin Hellgren et al. ARTHRITIS AND RHEUMATISM
- The risk of cancer in patients with rheumatoid arthritis: A nationwide cohort study in Taiwan
- (2010) Yi-Ju Chen et al. ARTHRITIS AND RHEUMATISM
- Golimumab for Rheumatoid Arthritis: A Systematic Review
- (2010) J. A. SINGH et al. JOURNAL OF RHEUMATOLOGY
- Meta-analysis of the Efficacy and Safety of Adalimumab, Etanercept, and Infliximab for the Treatment of Rheumatoid Arthritis
- (2010) Astrid Wiens et al. PHARMACOTHERAPY
- Incidence of malignancy in Japanese patients with rheumatoid arthritis
- (2010) Toru Yamada et al. RHEUMATOLOGY INTERNATIONAL
- Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT
- (2010) Anja Strangfeld et al. ARTHRITIS RESEARCH & THERAPY
- Single-center series and systematic review of randomized controlled trials of malignancies in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis receiving anti-tumor necrosis factor α therapy: Is there a need for more comprehensive screening procedures?
- (2009) Carlotta Nannini et al. ARTHRITIS AND RHEUMATISM
- A meta-analysis of the efficacy and safety of using infliximab for the treatment of rheumatoid arthritis
- (2009) Astrid Wiens et al. CLINICAL RHEUMATOLOGY
- A systematic review and meta-analysis of the efficacy and safety of adalimumab for treating rheumatoid arthritis
- (2009) Astrid Wiens et al. RHEUMATOLOGY INTERNATIONAL
- A Systematic Review and Meta-analysis of the Efficacy and Safety of Etanercept for Treating Rheumatoid Arthritis
- (2009) Astrid Wiens et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events
- (2008) J P Leombruno et al. ANNALS OF THE RHEUMATIC DISEASES
- American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
- (2008) Kenneth G. Saag et al. ARTHRITIS AND RHEUMATISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started